US Patent Issued to Regeneron Pharmaceuticals on Feb. 3 for "Mouse having a humanized b-cell activating factor gene" (American, Italian Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,538,905, issued on Feb. 3, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Mouse having a humanized b-cell activating factor gene" was invented by John McWhirter (Sanremo IM, Italy), Cagan Gurer (Chappaqua, N.Y.), Lynn Macdonald (Harrison, N.Y.) and Andrew J. Murphy (Croton-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Non-human animals, cells, methods and compositions for making and using the same are provided, wherein the non-human animals and cells comprise a humanized B-cell activating factor gene. Non-human animals and cells that express a human or humanized B-cell activating factor protein from an endogenous B-ce...